Spring Creek Capital’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Spring Creek Capital’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-370,000	Closed	-$80.3M	–	743
2021 Q1	$80.3M	Buy	+370,000	New	+$69.5M	3.47%	6

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Spring Creek Capital's GWPH Position: Q2 2021 in Review

Spring Creek Capital sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 370,000 shares — an estimated $80.3M sold.

Spring Creek Capital first reported a position in GWPH in Q1 2021 and held it in 1 quarter. The position peaked at $80.3M in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Spring Creek Capital reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Spring Creek Capital sold 370,000 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $80.3M.
Spring Creek Capital first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2021 and held it in 1 quarter.
Spring Creek Capital's GW Pharmaceuticals Plc American Depositary Shares position peaked at $80.3M in Q1 2021.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Spring Creek Capital's 13F filing for Q2 2021, filed 13 Aug 2021.